Pfizer — Press Releases Health Press Releases — RSS Feed & Live Monitoring
PPN World tracks the Pfizer — Press Releases RSS feed in real time — 2 releases indexed over the last 30 days, the newest arrived 2 d ago. Follow it with saved-search alerts, AI summaries, and full-text search, or plug the RSS URL below into your own reader.
Pfizer — Press Releases RSS feed URL
https://investors.pfizer.com/rss/pressrelease.aspxAbout this feed
Pfizer — Press Releases is one of the 1000+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed under United States in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. Pfizer — Press Releases is a low-volume specialist wire — 2 releases over the last 30 days: the kind of source worth an alert rather than a scroll.
How to follow Pfizer — Press Releases press releases
- Copy the Pfizer — Press Releases RSS feed URL shown above.
- Paste it into any RSS reader (Feedly, Inoreader, NetNewsWire…) to get the raw feed.
- Or track Pfizer — Press Releases in PPN World to add deduplication, saved-search alerts, and AI summaries across all 1000+ wires.
Latest Pfizer — Press Releases press releases
- FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer2 d ago
- U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility14 d ago
- Pfizer Declares Third-Quarter 2026 Dividend30 d ago
- FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance30 d ago
- Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts31 d ago
- Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer32 d ago
- Pfizer Announces Chief Financial Officer Transition37 d ago
- U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need47 d ago
- Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide49 d ago
- Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference53 d ago
The newest releases on this wire stream live for PPN World members.